Aehr Test Systems
AEHRNasdaqCIK 1040470TechnologyFiscal year ends Dec 31
Reports and events: 288 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-26-009242 |
| 2026-10-2017:04 ET | 8-K | 5.07 Shareholder vote results | 0001654954-26-009056 |
| 2026-09-0916:06 ET | DEF 14A | Proxy statementPeriod 2026-09-03 | 0001654954-26-008222 |
| 2026-07-2716:18 ET | 10-K | Annual reportPeriod 2026-05-29 | 0001654954-26-006919 |
| 2026-07-1416:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-006655 |
| 2026-04-2017:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-003746 |
| 2026-04-0816:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-26-003355 |
| 2026-04-0816:05 ET | 10-Q | Quarterly reportPeriod 2026-02-27 | 0001654954-26-003348 |
| 2026-04-0716:28 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-26-003310 |
| 2026-01-1216:07 ET | 10-Q | Quarterly reportPeriod 2025-11-28 | 0001654954-26-000266 |
| 2026-01-0817:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-000197 |
| 2025-11-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-25-012704 |
| 2025-10-2116:21 ET | 8-K | 5.07 Shareholder vote results | 0001654954-25-012028 |
| 2025-10-0816:13 ET | 10-Q | Quarterly reportPeriod 2025-08-29 | 0001654954-25-011582 |
| 2025-10-0616:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-011494 |
| 2025-09-1016:01 ET | DEF 14A | Proxy statementPeriod 2025-09-03 | 0001654954-25-010620 |
| 2025-07-2817:05 ET | 10-K | Annual reportPeriod 2025-05-30 | 0001654954-25-008553 |
| 2025-07-0816:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-007859 |
| 2025-04-1016:06 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001654954-25-004120 |
| 2025-04-0817:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-004020 |
| 2025-02-2816:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-25-002152 |
| 2025-01-1316:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-000292 |
| 2025-01-1316:06 ET | 10-Q | Quarterly reportPeriod 2024-11-29 | 0001654954-25-000285 |
| 2024-10-2216:03 ET | 8-K | 5.07 Shareholder vote results | 0001654954-24-013223 |
| 2024-10-1117:21 ET | 10-Q | Quarterly reportPeriod 2024-08-30 | 0001654954-24-012913 |
| 2024-10-1016:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-012870 |
| 2024-09-1116:16 ET | DEF 14A | Proxy statementPeriod 2024-09-11 | 0001654954-24-011751 |
| 2024-09-0617:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-011548 |
| 2024-08-0116:05 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001654954-24-009808 |
| 2024-07-3016:22 ET | 10-K | Annual reportPeriod 2024-05-31 | 0001654954-24-009642 |
| 2024-07-1617:22 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-24-009013 |
| 2024-07-1617:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-009008 |
| 2024-07-0916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-008746 |
| 2024-05-2907:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-006995 |
| 2024-04-1016:28 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001654954-24-004455 |
| 2024-04-0916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-004414 |
| 2024-01-1216:51 ET | 10-Q | Quarterly reportPeriod 2023-11-30 | 0001654954-24-000525 |
| 2024-01-1016:43 ET | 8-K | 1.02 Termination of a material agreement | 0001654954-24-000428 |
| 2024-01-0916:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-000372 |
| 2023-10-2516:18 ET | 8-K | 5.07 Shareholder vote results | 0001654954-23-013387 |
| 2023-10-1216:16 ET | 10-Q | Quarterly reportPeriod 2023-08-31 | 0001654954-23-012844 |
| 2023-10-0517:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-012655 |
| 2023-09-1316:01 ET | DEF 14A | Proxy statementPeriod 2023-10-23 | 0001654954-23-011818 |
| 2023-08-2816:06 ET | 10-K | Annual reportPeriod 2023-05-31 | 0001654954-23-011271 |
| 2023-07-1716:59 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-23-009282 |
| 2023-07-1316:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-009130 |
| 2023-05-3116:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-23-007424 |
| 2023-05-3116:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-23-007423 |
| 2023-04-1316:24 ET | 10-Q | Quarterly reportPeriod 2023-02-28 | 0001654954-23-004701 |
| 2023-03-3106:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-23-003965 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:22 ET. Listed shows no prices and gives no investment advice.